Wildcat Capital Management, LLC Portfolio Holdings
Wildcat Capital Management, LLC
- $252 Million
- Q4 2024
Wildcat Capital Management, LLC has filed its 13F form on January 29, 2025 for Q4 2024 where it was disclosed a total value porftolio of $252 Million distributed in 8 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Frontier Group Holdings, Inc. with a value of $200M, Rlx Technology Inc. with a value of $39M, Allogene Therapeutics, Inc. with a value of $6.22M, Uro Gen Pharma Ltd. with a value of $5.28M, and Kronos Bio, Inc. with a value of $1.23M.
Examining the 13F form we can see an increase of $48.1M in the current position value, from $204M to 252M.
Below you can find more details about Wildcat Capital Management, LLC portfolio as well as his latest detailed transactions.